We’re pleased to announce that Quinn Emanuel Partner Frank Calvosa has been recognized by Law360 as a Rising Star in the Life Sciences category!
Frank was highlighted for his exceptional work in the Jazz Pharmaceuticals' jury trial victory that protected their $1.8 billion market for oxybate, a critical treatment for daytime sleepiness. His strategic brief writing and coordination of a 20+ person legal team showcased the kind of leadership that sets rising stars apart.
What stands out most? Frank's passion for understanding his clients' innovative stories - from breakthrough compounds to new disease treatments. As he puts it: "These people are figuring out innovative solutions... and their story often gets overlooked."
Read the article here.
Learn more about Frank’s practice here.